General informationNotification NumberB/HU/06/11/7Member State to which the notification was sentHungaryDate of acknowledgement from the Member State Competent Authority04/12/2006Title of the ProjectThree year field trials programme (2007-2009) for the deliberate release of MON 88017 maize protected against certain coleopteran insect pests (Diabrotica spp) and tolerant to glyphosateProposed period of release:01/04/2007 to 31/12/2009Name of the Institute(s) or Company(ies)Monsanto Kereskedelmi Kft, ;
3. Is the same GMPt release planned elsewhere in the Community?Yes: Germany; Spain; France; Has the same GMPt been notified elsewhere by the same notifier?YesIf yes, notification number(s): B/DE/05/169; B/ES/06/02; B/FR/05/04/01; B/FR/06/01/02; B/HU/06/11/6; Genetically modified plantComplete name of the recipient or parental plant(s)
2. Description of the traits and characteristics which have been introduced or modified, including marker genes and previous modifications:maize MON 88017 that will be tested in these field trials is protected to certain coleopteran insect pests (Diabrotica spp) and is tolerant to glyphosate herbicide.Genetic modification3. Type of genetic modification:Insertion; In case of insertion of genetic material, give the source and intended function of each constituent fragment of the region to be inserted:MON 88017 contains the following genetic elements :
|Common Name||Family Name||Genus||Species||Subspecies||Cultivar/breeding line|
- the cry3Bb1 gene from Bacillus thuringiensis subsp. kumamotoensis which confers protection against certain coleopteran pests (Diabrotica spp)
- the cp4 epsps gene from Agrobacterium sp. strain CP4, which provides tolerance to ghyphosate herbicide.
These genes have been introduced with regulatory elements necessary for expressioin in plant cells.6. Brief description of the method used for the genetic modification:MON 88017 was produced by Agrobacterium-mediated transformation of immature embryos of maize tissue.7. If the recipient or parental plant is a forest tree species, describe ways and extent of dissemination and specific factors affecting dissemination:Not applicableExperimental Release1. Purpose of the release:Purpose of the release is to evaluate effect of MON 88017 on non target organisms2. Geographical location of the site:Füle
Bölcske3. Size of the site (m2):3600 m24. Relevant data regarding previous releases carried out with the same GM-plant, if any, specifically related to the potential environmental and human health impacts from the release:Many field trials have already been conducted at several locations across maize growing regions in North and South America. No environmental problems were reported for these trials. Except for its protection against certain coleopteran insects and its tolerance to glyphosate herbicide, MON 88017 could not be distinguished from conventional maize.
No risk to human and animal health.
Insect-protection and glyphosate tolerance traits present in MON 88017 are present, alone or in combination, in commercial products, NK603, MON 863 and MON 863 x NK603, which have a safety commercial experience.Environmental Impact and Risk ManagementSummary of the potential environmental impact from the release of the GMPts: Analysis of the characteristics of MON 88017 maize, especially in comparison with extensive experience with cultivation of conventional maize within the E.U., has shown that the risk for potential adverse effects on human and animal health and the receiving environment, resulting from the planned field trials with MON 88017 maize, is negligible:
• The risk of the introduced traits in MON 88017 maize to be the cause of any meaningful competitive advantage or disadvantage in natural environments is negligible. As for any other maize, the likelihood of this maize to spread into non-agronomic environments is negligible, as its persistence in agricultural habitats and its invasiveness into natural habitats are unaltered compared to conventional maize.
• Potential exposure of non-target organisms to CP4 EPSPS presents no conceivable mechanism to cause adverse effects because of its properties. Due to the high selectivity of Cry3Bb1 protein to certain coleopteran insects and based on studies with different species, the risk for non target organisms is considered negligible. The ecological interactions of MON 88017 maize with non target organisms or soil process are considered similar to the respective caused by conventional corn
• Any occupational health aspects of handling MON 88017 maize are not different from conventional maize, and this maize was shown to be as safe and as nutritious as any other maize.
• The environmental impact of the cultivation, management and harvesting techniques applied in the planned trials is considered no different from the farming practices for conventional maize.
It is actually expected that the commercial production of MON 88017 maize will positively impact current agronomic practices in maize and provide benefits to farmers and the environment. The protection against D. virgifera would offer a new tool for IPM and would reduce the reliance on chemical pesticides whereas the use of glyphosate in maize would enable the farmer to take advantage of the herbicide’s favorable environmental and safety properties (see Annex I listing of glyphosate under Council Directive 91/414/EEC) as well as facilitate adoption of conservation tillage practice in corn production
Maize can hybridize with teosinte but these plants are not present in Europe. Measures will be taken to avoid hybridization with other maize plants and seed dissemination at harvest and during transportation.Brief description of any measures taken for the management of risks:1. In addition to the scheduled observations of phenotypic and agronomic parameters that form the basis of the planned research, the trial site will be checked regularly during the period of the deliberate release for potentially occurring, direct or indirect, adverse environmental effects. This will be done by visual inspection of the status of the MON88017 crop and that of its receiving environment. In case any adverse environmental effects, linked to the deliberate release of MON 88017, are observed during the period of release, these will be reported immediately to the Competent Authority.
The spatial isolation distance (500 m) from other maize crops and the six rows of conventional maize surrounding the trials will prevent most of the possibility of hybridisation with other maize plants.
2. The equipment, especially the experimental drill and combine, will be cleaned on the experimental site, thus preventing seed dissemination.
After completion of harvest, the stalks (whole plant in the NTO trials, and efficacy after yield measurement) will be chopped and then incorporated into the soil. Any shattered seed will be allowed to germinate. The resulting seedlings will be destroyed by soil incorporation.
3. Although regrowth in the rotation crops is unlikely because of poor winter survival, the site will be sown with a crop different from maize. Volunteer plants will be controlled by the use of routinely used commercial antimonocotyledonous herbicides in this crop or removed by hand.
4. Seeds will be transported in sealed, double wall and labelled bags placed in a rigid container.Summary of foreseen field trial studies focused to gain new data on environmental and human health impact from the release:Non target organism studies:
The impact of MON 88017 will be tested on non target soil dwelling and predatory foliar arthropods, including carabids, from seedling stage (V2 – V4) through physiological maturity (R6). The abundance of the evaluated non target organisms in MON 88017 will compared to the most frequently used conventional protection (seed and soil insecticide treatment) methods as well as near iso hybrid.
-Pitfall traps to capture soil dwelling arthropods,
Carabids: 4-5 species (required)
Staphylinids: 1 species or functional group (family)
Wire worms (click beetles)
Spiders (functional group)
-Sticky traps deployed for beneficial/ predatory foliar insects and arthropods
Coccinellids: 1 species (or functional group)
Randomized complete block design, 30 x 30 m plot size
4 replications (plots)/treatment
Any unanticipated adverse effects on human health or the environment would be reported immediately to the Competent Authority.Final report-European Commission administrative informationConsent given by the Member State Competent Authority:Not known